Rigel Pharmaceuticals, Inc.

as Exhibit 99.1 hereto. The information in this report, including the exhibit hereto, shall not be deemed to be “filed” for purposes of Section 18 of the Securi

. Financial Statements and Exhibits. (d) Exhibits. Exhibit Description 99.1 Press Release, dated March 3, 2026, titled “Rigel Provides Fourth Quarter and Full Y